Search Results for 'Dolutegravir'

Dolutegravir published presentations and documents on DocSlides.

Dolutegravir plus Rilpivirine as Maintenance Dual Therapy

quinn
13 Slides

SWORD-1 . and SWORD-. 2. Dolutegravir plus Rilpivi...

Dolutegravir + 2 NRTIs versus Darunavir + RTV + 2 NRTIs

roxanne
9 Slides

FLAMINGO. Dolutegravir + 2 NRTIs versus Darunavir ...

Dolutegravir vs. Raltegravir

zoe
9 Slides

SPRING-2 Study. Dolutegravir. versus Raltegravir....

Dolutegravir ( Tivicay )

brown
100 Slides

Prepared by:. Brian R. Wood, MD. David H. Spach, M...

2013 Asilomar HIV Medical Update

luanne-stotts
74 Slides

David Spach, MD. Clinical Director, Northwest AET...

New regimen for $75 a year

tawny-fly
0 Slides

New pricing agreement will speed up access to gen...

Working Group on Modelling Potential Responses to High Levels of pre-ART Drug Resistance in Sub-Sah

debby-jeon
0 Slides

HIV Drug Resistance (HIVDR) and Antimicrobial Res...

New Antiretrovirals for the Treatment

alida-meadow
0 Slides

of HIV. . Convenience, tolerability, simplicity....

Dolutegravir-Lamivudine (

audrey
43 Slides

Dovato. ). Last Updated: November 28, 2022. Prepar...

Update from CROI 2023: Snippets from Seattle

scarlett
28 Slides

Judith S. Currier, MD, MSc. Professor of Medicine....

Antiretroviral Updates:

tatyana-admore
0 Slides

New Treatments for HIV. C. Ryan Tomlin, . Pharm.D...

Superior Efficacy of Dolutegravir (DTG) Plus

celsa-spraggs
0 Slides

2 Nucleoside Reverse Transcriptase Inhibitors (NR...

MPP LICENCES AND OPPORTUNITIES FOR INTRODUCTION OF NEW PRODUCTS AND FORMULATIONS

cheryl-pisano
0 Slides

Esteban Burrone, . July 2017. THE MEDICINES PATEN...

Projecting the Impact of

marina-yarberry
0 Slides

Generic. HIV . Drugs. on 90-90-90. Esteban Burr...

HIV Pharmacotherapy Focused Update

yoshiko-marsland
0 Slides

Drew Lambert, . PharmD. lambertd@husson.edu. Huss...

HIV 2015-2016: New Agents, New Strategies

ellena-manuel
0 Slides

Learning Objectives. EARLY VS DEFERRED ART. The C...

Essentials for Optimal Care of HIV Patients

marina-yarberry
0 Slides

Evidence-Based Approaches. Simply Speaking. ®. ...

ACTHIV 2018: A State-of-the-Science Conference for Frontline Health Professionals

phoebe-click
0 Slides

ACTIVITY CODE . TD342. Antiretroviral Medications...

Dolutegravir monotherapy

alexa-scheidler
15 Slides

Dolutegravir monotherapy vs. dolutegravir/ abac...

Heather Watts MD Director of HIV Prevention, Program Quality Team

alida-meadow
22 Slides

Heather Watts MD Director of HIV Prevention, Pro...

Paediatric ARV Drug Optimization 3 Review Summary report &

neoiate
15 Slides

*\n\b...

Interactive ART Cases From the Clinic: Is There One Right Answer?

megan
44 Slides

Joseph J. Eron, Jr, MD. Professor of Medicine. Uni...

Effect of dolutegravir on folate and vitamin B12 status among HIV-infected children and adolescents

ethlyn
9 Slides

Linda Barlow-Mosha*. 1. , Grace Miriam . Ahimbisib...

DURABLE EFFICACY OF DOLUTEGRAVIR (DTG) PLUS LAMIVUDINE (3TC) IN ANTIRETROVIRAL TREATMENT

jasmine
15 Slides

–. NAIVE ADULTS WITH HIV-1 INFECTION: 96-WEEK RE...

Dolutegravir Containing

unita
16 Slides

R. egimens . m. ay Need . O. ptimization for Youth...

Cases from the Clinic(ians): Case-based Panel Discussion

tripp
15 Slides

Associate Dean for Global Health. University of Al...